Operator Good day, everyone, and welcome to the Exact Sciences fourth quarter 2024 earnings call. Today's call is being ...

Exact Sciences reports strong Q4 2024 growth, unveils 2025 plans with 11% revenue growth forecast & Cologuard Plus launch.

Good day everyone and welcome to the Exact Sciences fourth quarter 2024 earnings call. Today's call is being recorded. (Operator Instructions). I would now like to turn the conference over to Derek ...

Two employers sued over the health law mandate that requires preventive care coverage but a testing firm CEO think other ...

Good day, everyone, and welcome to the Exact Sciences Fourth Quarter 2024 Earnings Call. Today's call is being recorded. All lines have been placed on mute to prevent any background noise. After the ...

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q4 CY2024, with sales ...

The company best known for its Cologuard colon cancer screening test posted a loss of $864.6 million, or $4.67 per share, on ...

Exact Sciences Corp (NASDAQ:EXAS) reported fourth-quarter financial results after the market close on Wednesday. Here's a ...

Sean Allen and Victoria Matiash make their betting picks for the second half of the NHL season, one for every team.

A-Leagues commissioner Nick Garcia is set to depart his position at the Australian Professional Leagues (APL) multiple ...

Reports Q4 revenue $713.42M, consensus $701.45M. “The Exact Sciences (EXAS) team is off to a good start in 2025, building on the momentum we ...

Explore the ultimate list of superhero movies, from Marvel to DC, filled with action, epic battles, inspiring heroes, and ...